Today’s AI Top Pick: TIGR
7/7/2026 · Recently Alerted Turnaround screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live TIGR price forecast →
UP Fintech (TIGR) is the cleanest setup on the board today: it's the rare name where valuation, growth, forecasts across every timeframe, and range position all line up in the buyer's favor. Fundamentals are the standout — trailing PE 7.7, fwdPE 5.92, PEG-friendly, operMargin 45.3%, grossMargin 95.15%, salesYoY +48.35%, epsNextY +63.97%, ROE 14.8%, recom 1.6, and a targetUpsidePct of 51%. It also has the highest expected_return_pct (89.3%) of any name that isn't a lottery ticket (SDA), with fundamental_score 7.5 and bullish_prob 1.0. The tape agrees. 1h forecasts: fc_short +4.2%, fc_mid +17.11%, fc_long +47.79%. 4h: fc_mid +75.05%, fc_long +68.64%. 1d: fc_short +46.23%, fc_mid +57.27%, fc_long +59.15%. 1wk: fc_mid +48.18%, fc_long +41.72%. That's four-timeframe agreement with mid/long horizons all double-digit-plus positive — the profile the framework explicitly rewards. Crucially, TIGR is NOT extended: 1wk pos_in_21bar_range is only 6.45% with a -43.07% weekly drawdown from the 21-bar high, 1d pos is 46.51%, and 4h pos is 53.76%. You're buying deep-value-cheap after a washout, not chasing a top. News check is supportive rather than a landmine: recent Insider Monkey coverage flags it as an attractive small-cap financial, and the fair-value target trim from Simply Wall St. is minor — no guidance cut, no litigation, no dilution, no short-seller report. Contrast that with PODD (FDA Class-serious Omnipod recall + Evercore PT cut — an immediate disqualifier for #1 despite screamer forecasts) and CALX (class-action deadline noise + pinned at 100% of daily range = chasing). TMDX has huge forecasts but a 23% short float and is 51% off its weekly high with distribution risk; ORCL is deeply oversold and interesting but the 4h/weekly tape is still messy after a -35% weekly drawdown. Today is the entry because TIGR is coiled at the lower end of its weekly range with positive multi-TF forecasts, cheap on both trailing and forward multiples, and lacks any material negative catalyst. Waiting risks missing the 46% fc_short daily move if the reversion trade fires this week.
- China/ADR regulatory overhang — TIGR is a Chinese ADR (Perf 1Y -50.64%); a single ADR/HK crackdown headline can override the forecast tape.
- 1wk drawdown -43.07% from 21-bar high signals the primary trend is still broken; a failed reversal could retest lows near $4.00.
- Low absolute price ($4.60) and small cap ($840M) mean liquidity gaps and higher slippage on stops.
- Institutional ownership only 30.97% — thin sponsorship compared with peers (BX 44%, ARES 94%), meaning less institutional bid support on dips.
- Broker/fintech revenue is highly correlated to Asian retail trading volumes; a risk-off month can compress the +48% sales growth narrative quickly.
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | TIGR | BUY NOW | 8.6 | Multi-TF forecasts all green (1d fc_mid +57%, 1wk +48%), fwdPE 5.92, oversold at 6% of weekly range — cleanest reversion setup on the board. |
| 2 | TMDX | BUY NOW | 8.2 | Bullish_prob 1 with 4h fc_long +124% and 1d fc_mid +66%, pe 16.35 and roe 45%; 23% short float adds squeeze fuel and risk. |
| 3 | ORCL | BUY NOW | 7.8 | Oversold blue-chip reversion — RSI 30, 6.46% of daily range, roe 54%, 1d forecasts +21%/+28%/+26%, positive analyst chorus. |
| 4 | YMM | BUY NOW | 7.5 | PE 15.84, profitMargin 32.7%, operMargin 31%, four-TF forecasts positive (1d fc_short +29.5%), JPM upgrade tailwind. |
| 5 | NAGE | BUY PULLBACK | 6.7 | 1d fc_short +92.6% and roe 27%, but 1wk forecasts all negative (-10/-27/-27) — chase risk despite strong daily setup. |
| 6 | CHWY | BUY PULLBACK | 6.6 | TD Cowen top SMID pick, 1d fc_mid +39%, 1wk fc_mid +77%, roe 63.8%; at 100% of 1h/1d range so wait for pullback. |
| 7 | SE | BUY PULLBACK | 6.5 | Bullish_prob 1, 1d fc_short +21.4%, salesYoY +40.5% and roe 14.7% — but 1h/1d pinned near 100% of range. |
| 8 | PSIX | BUY PULLBACK | 6.3 | PE 8.28, roe 75.7%, 1d fc_short +79.9%, but 1wk forecasts deeply negative (fc_long -62.7%); trend still broken. |
| 9 | MLCO | BUY PULLBACK | 6.2 | PEG 0.23, fwdPE 6.89, 1wk fc_mid +51%, near bottom of weekly range; Morgan Stanley downgrade a modest headwind. |
| 10 | SRAD | BUY PULLBACK | 5.9 | PEG 0.47, salesYoY +24.4%, 1d forecasts +12/+11/+9, but 1wk fc all negative (-9/-24/-14). |
| 11 | CALX | BUY PULLBACK | 5.8 | PEG 0.41, 1d fc_short +20%, but at 100% of daily range and class-action deadline overhang — don't chase. |
| 12 | NOW | BUY PULLBACK | 5.7 | Bullish_prob 1 and AI/defense wins narrative, 1d fc_mid +38.5%, but 1h forecasts negative and pos_1h 100%. |
| 13 | BX | BUY PULLBACK | 5.6 | Quality asset manager, roe 37.4%, salesYoY +17.8%, Russell Value tailwind — but modest forecast magnitude (fc_mid +12%). |
| 14 | RBBN | BUY PULLBACK | 5.5 | 1d fc_long +41%, 1wk fc_mid +72.6%, deep drawdown at 9% of 1d range — but salesYoY -1.15% and operMargin 0.64%. |
| 15 | CELH | BUY PULLBACK | 5.4 | SalesYoY +123%, 1d fc +25%/+26%/+23%, but 1h/4h fc_short negative and SA article warns 'one-brand era is over.' |
| 16 | IDN | BUY PULLBACK | 5.3 | 1h fc_long +81%, 4h fc_mid +47%, added to Russell — but 1wk fc essentially flat and micro-cap ($85M). |
| 17 | MNTN | WAIT | 5.2 | RSI 69.4 near overbought, at 100% of 1h/4h/1d range, 1h forecasts negative — extended, wait for retrace. |
| 18 | KKR | WAIT | 5.1 | Solid PE 32.7 and epsNextY +21.8%, 1d fc_mid +21%, but 4h/1wk fc_short negative and Moody's Asia slowdown flag. |
| 19 | ARES | WAIT | 5.0 | SalesYoY +47%, oversold call from SA, 1d fc_mid +13.5%, but 1wk fc_short -11.6% and near-term choppy. |
| 20 | HSAI | WAIT | 4.9 | SalesYoY +44%, 1d fc_short +36%, but 1wk forecasts all negative (-0.3/-2/-2.9) — trend not confirmed. |
| 21 | JBI | WAIT | 4.7 | FwdPE 8.21 and epsNextY +23.5%, but salesYoY -2.5%, StockStory warning flag, minimal news catalyst. |
| 22 | SDA | AVOID | 4.6 | PE 500, marketCap $92M, profitMargin 0.04%; forecasts are lottery-ticket magnitudes (1wk fc_long +792%), not investable. |
| 23 | TOST | WAIT | 4.5 | RSI 69.45 hot, at 100% of 1h/1d range, 1h/4h forecasts negative — thesis intact but entry is bad. |
| 24 | SPOT | WAIT | 4.4 | PEG 1.19, roe 39.6% — quality, but 1h/4h/1d/1wk fc_short all negative and PEG the highest of the top-scored group. |
| 25 | WING | WAIT | 4.3 | FwdPE 30.67 with epsNextY only 22%, shortFloat 16%, PEG 1.6 — richest valuation in the pool without matching forecasts. |
| 26 | AVPT | WAIT | 4.2 | RSI 69.95, at 100% of 1h/1wk range, 1h/1wk forecasts all negative — overbought, not a buy today. |
| 27 | MAIA | WAIT | 4.0 | Roe -148%, no revenue, biotech binary; fwdPE 1.3 headline is meaningless without approval catalyst. |
| 28 | VTEX | AVOID | 3.6 | PE 41,300, near_term_bullish 0, 1h/4h forecasts all negative — screen pass but tape is broken. |
| 29 | HNI | AVOID | 3.4 | RSI 77.95 extreme overbought, PE 97.4, profitMargin 0.04%, 1h/4h/1wk forecasts negative — reversal pending. |
| 30 | PODD | AVOID | 3.0 | Forecasts screamer (1d fc_short +49%) but FDA classified Omnipod recall as SERIOUS with injuries — landmine that disqualifies #1 candidacy. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord